Jazz Pharmaceuticals (JAZZ) Interest & Investment Income: 2009-2025
Historic Interest & Investment Income for Jazz Pharmaceuticals (JAZZ) over the last 16 years, with Sep 2025 value amounting to -$48.6 million.
- Jazz Pharmaceuticals' Interest & Investment Income rose 17.25% to -$48.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$212.2 million, marking a year-over-year increase of 17.47%. This contributed to the annual value of -$238.1 million for FY2024, which is 17.74% up from last year.
- Jazz Pharmaceuticals' Interest & Investment Income amounted to -$48.6 million in Q3 2025, which was up 9.55% from -$53.7 million recorded in Q2 2025.
- In the past 5 years, Jazz Pharmaceuticals' Interest & Investment Income ranged from a high of -$27.4 million in Q1 2021 and a low of -$93.4 million during Q3 2021.
- Moreover, its 3-year median value for Interest & Investment Income was -$64.1 million (2024), whereas its average is -$63.0 million.
- In the last 5 years, Jazz Pharmaceuticals' Interest & Investment Income slumped by 240.43% in 2021 and then climbed by 27.11% in 2024.
- Over the past 5 years, Jazz Pharmaceuticals' Interest & Investment Income (Quarterly) stood at -$88.6 million in 2021, then climbed by 16.34% to -$74.1 million in 2022, then climbed by 5.13% to -$70.3 million in 2023, then increased by 27.11% to -$51.3 million in 2024, then climbed by 17.25% to -$48.6 million in 2025.
- Its last three reported values are -$48.6 million in Q3 2025, -$53.7 million for Q2 2025, and -$51.3 million during Q4 2024.